Suppr超能文献

[从中药中发现孤儿受体BRS-3的外源性配体]

[Discovery of exogenous ligands for orphan receptor BRS-3 from Chinese herbs].

作者信息

Qiu Xin, Wu Le-Hao, Yu Yang, Jin Yu, Wang Ji-Xia, Wang Chao-Ran, Zhang Yan

机构信息

School of Pharmacy, Shanghai Jiao Tong University Shanghai 200240, China.

School of Pharmacy, East China University of Science and Technology Shanghai 200237, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2022 Mar;47(6):1595-1602. doi: 10.19540/j.cnki.cjcmm.20201112.201.

Abstract

Bombesin receptor subtype-3(BRS-3) is an orphan receptor in the bombesin receptor family. Its signal transduction mechanism and biological function have attracted much attention. Seeking the ligand for BRS-3 is of great significance for exploring its function. Considering the fact that the activation of BRS-3 receptor can induce the change in intracellular Ca(2+) concentration, the fluo-rometric imaging plate reader(FLIPR) was utilized for ligand screening at the cellular level. Among more than 400 monomeric compounds isolated from Chinese herbs, yuanhunine from Corydalis Rhizoma and sophoraisoflavanone A and licoriphenone from Glycyrrhizae Radix et Rhizoma antagonized BRS-3 to varying degrees. It was confirmed in HEK293 cells expressing BRS-3 that yuanhunine, sophoraisoflavanone A, and licoriphenone inhibited the calcium current response after the activation of BRS-3 by [D-Phe6,β-Ala(11),Phe(13),Nle(14)]bombesin-(6-14) in a dose-dependent manner with the IC_(50) values being 8.58, 4.10, and 2.04 μmol·L(-1), respectively. Further study indicated that yuanhunine and sophoraisoflavanone A exhibited good selectivity for BRS-3. In this study, it was found for the first time that monomers derived from Chinese herbs had antagonistic activity against orphan receptor BRS-3, which has provided a tool for further study of BRS-3 and also the potential lead compounds for new drug discovery. At the same time, it provides reference for the research and development of innovative drugs based on the active ingredients of Chinese herbs.

摘要

胃泌素释放肽受体亚型-3(BRS-3)是胃泌素释放肽受体家族中的一种孤儿受体。其信号转导机制和生物学功能备受关注。寻找BRS-3的配体对于探索其功能具有重要意义。鉴于BRS-3受体的激活可诱导细胞内Ca²⁺浓度变化,采用荧光成像酶标仪(FLIPR)在细胞水平进行配体筛选。从中药中分离得到的400多种单体化合物中,延胡索中的原阿片碱以及甘草中的槐属异黄酮A和甘草酚对BRS-3有不同程度的拮抗作用。在表达BRS-3的HEK293细胞中证实,原阿片碱、槐属异黄酮A和甘草酚能剂量依赖性地抑制[D-Phe⁶,β-Ala¹¹,Phe¹³,Nle¹⁴]胃泌素释放肽-(6-14)激活BRS-3后的钙电流反应,IC₅₀值分别为8.58、4.10和2.04 μmol·L⁻¹。进一步研究表明,原阿片碱和槐属异黄酮A对BRS-3具有良好的选择性。本研究首次发现中药来源的单体对孤儿受体BRS-3具有拮抗活性,为进一步研究BRS-3提供了工具,也为新药发现提供了潜在的先导化合物。同时,为基于中药活性成分的创新药物研发提供了参考。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验